Alector appoints Gary Romano, M.D., Ph.D., as CMO effective May 23, 2022

Alector, Inc.

Appointed Gary Romano, M.D., Ph.D., as Chief Medical Officer, effective May 23, 2022.
Annual base salary of $475,000; eligible for performance bonus of 40%; equity awards: $3.9M stock option (4-yr vest) and $975K RSU (3-yr vest).
He brings over 25 years of neurodegenerative disease experience, previously CMO at Passage Bio and roles at Janssen and Merck.
Interim CMO Sam Jackson, M.D., M.B.A., is leaving Alector to pursue a new opportunity; will continue as a consultant.
He will report to President and Head of R&D Sara Kenkare-Mitra.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Gary Romano, Ph.D., M.D.

Chief Medical Officer

ALEC · Alector, Inc.

Effective: 2022-05-23
Filed: March 29, 2022, 7:59 PM ET

On March 29, 2022, Alector, Inc. (“Alector”) announced the appointment of Gary Romano, Ph.D., M.D., as Alector’s Chief Medical Officer , effective May 23, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Gary Romano, Ph.D., M.D. was appointed as Chief Medical Officer at Alector, Inc..

Action: appointed
Role: Chief Medical Officer

Exact text from the filing

On March 29, 2022, Alector, Inc. (“Alector”) announced the appointment of Gary Romano, Ph.D., M.D., as Alector’s Chief Medical Officer , effective May 23, 2022.

View on SEC.gov

Alector, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-22-004925

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.